Introduction
Mitochondrion appears to be the key regulator of programmed cell death. Mitochondrial DNA (mtDNA) is constantly subjected to damage by many cellular processes such as spontaneous depurination or deamination and by endogenous and environmental mutagens (Krokan et al., 2000) and also through replication and repair errors (Chi and Kolodner, 1994) . Because of the lack of protective histones, the accumulation of mutations in mitochondria is approximately 10-fold higher than that in nuclear DNA (Lightowlers et al., 1997; Yakes and Van Houten, 1997; Singh et al., 2001) . A wide range of DNA lesions that include single-and double-strand DNA breaks, apurinic-apyrimidinic (AP) sites, DNA-protein cross-links and oxidized DNA bases are a result of predisposition of mtDNA to chemical damage (Dizdaroglu, 1991; Cadet et al., 1997) . One of the important mtDNA repair mechanisms is base excision repair (BER), and the detection of various BER enzymes in mitochondria highlights the importance of maintaining mtDNA integrity for normal cellular functioning Shokolenko et al., 2003) . Likewise, mtDNA integrity has been targeted for enhanced cancer chemotherapy by overexpressing Escherichia coli exonuclease III or N-methylpurine DNA glycosylase in the mitochondria of human breast cancer cells (Fishel et al., 2003; Shokolenko et al., 2003) .
2-Methoxyestradiol (2-ME) is an endogenous metabolite of 17b-estradiol and has been reported to induce mitochondria-mediated apoptosis. Several mechanisms have been implicated including inhibition of mitochondrial respiration, accumulation of cells in the G 2 /M phase and inhibition of mitochondrial superoxide dismutase (Huang et al., 2000; Lambert et al., 2002 Lambert et al., , 2004 Qanungo et al., 2002; Djavaheri-Mergny et al., 2003a, b; Pelicano et al., 2003; Hagen et al., 2004) . Recent studies by Achanta and Huang (2004) demonstrated that 2-ME treatment in colon cancer cell lines led to a significant increase in 8-oxoG levels (also known as 7,8-dihydro-8-oxoguanine or 8-hydroxyguanine). It has been shown that the presence of 8-oxoG results in the incorporation of deoxyadenosine triphosphate opposite 8-oxoG during the replication yielding G:C to T:A transversions (Wood et al., 1990; Moriya et al., 1991; Cheng et al., 1992; Grollman and Moriya, 1993) . Since 8-oxoG constitutes a premutagenic lesion, efficient repair mechanisms are vital to prevent these lesions from becoming permanent mutations (Grollman and Moriya, 1993; Tajiri et al., 1995) . To maintain proper genetic integrity and to minimize cancer risk, organisms ranging from E. coli to humans have evolved elaborate mechanisms for repairing 8-oxoG Hazra et al., 2001) . In humans, 8-oxoG incorporated into DNA is removed by hOgg1, a DNA glycosylase/AP lyase that specifically incises 8-oxoG opposite cytosine . Earlier studies have shown that cellular survival and mtDNA repair can be enhanced by targeting wild-type hOGG1 to the mitochondria (Dobson et al., 2000; Rachek et al., 2002; Chatterjee et al., 2006) , suggesting that this gene is critical for the maintenance of the mitochondrial genome and cellular survival in response to DNA damage. We found that mitochondrialy targeted hOGG1 (MTS-hOGG1) protects HeLa cells (normally expressing very low levels of hOGG1) from 2-ME damage and its subsequent effects.
Results

Dox-dependent overexpression of OGG1 in mitochondria
Mitochondrial extracts were isolated from MTS-OGG1 and vector-only HeLa-transfected clones that were cultured in Dulbecco's modified Eagle's medium (DMEM) with or without doxycycline (Dox). Western blot analysis revealed that the Tet-Off/MTS-OGG1-1 Dox À clone showed an increase in Ogg1 protein (39 kDa) when compared with Dox þ Tet-Off/MTS-OGG1-repressed cells or vector-transfected cells (Figure 1a ). This data confirmed that the recombinant Ogg1 enzyme was targeted to mitochondria and that hOGG1 gene expression was regulated by Dox. To examine the effect of 2-ME on recombinant hOgg1, we induced the hOgg1 protein expression in MTS-hOGG1 and vector-only-transfected clones by withdrawing Dox for 3 days and thereafter treating the cells with 2-ME for 24 h. Western blot analysis showed that 2-ME did not affect the expression and transport of hOgg1 in the mitochondria. (Figure 1b ).
MTS-hOGG1 enhances cellular survival in response to 2-ME treatment To determine whether overexpression of hOgg1 in mitochondria had any effect on cellular survival following the exposure of cells to 2-ME, we performed the MTT cell proliferation assay. The cells were exposed to 2-ME in concentration-dependent and time-dependent manner. MTT is a tetrazolium salt that is reduced by fully functioning mitochondria and results in a change of color from yellow to purple. Thus, the reduction of MTT can be monitored spectrophotometrically (Alley et al., 1988) . Therefore, a change in mitochondrial function and cell viability can be assayed using MTT as shown previously (Yakes and Van Houten, 1997) . HeLa cells transfected with MTShOGG1 were less sensitive to 2-ME when exposed for 24 h, compared to cells transfected with vector-only ( Figure 2a , compare black diamond with black triangle). IC 50 was >40 mM in the presence of hOGG1 compared to the vector-only-transfected cells (IC 50 , o5 mM). Our results also indicate that MTS-hOGG1 resulted in less cell death upon exposure to 5 and 20 mM 2-ME for 48 and 72 h (Figures 2b and c , compare dotted white bar with stripped bar). Treatment of the vector-onlytransfected cells with Fas inhibitors cerulenin and C75 (see rationale below) also resulted in the inhibition of the cell death inflicted by 2-ME, with a shift in the IC 50 of the vector-only-transfected cells to >40 mM (Figure 2d , see closed diamond and closed triangle).
Resistance to Dc m alteration by 2-ME in the presence of hOGG1 As our MTT results showed a higher sensitivity to 2-ME in the absence of hOGG1, which implicate an effect on mitochondrial function, we studied changes in the mitochondrial membrane potential of the HeLa cells in response to 2-ME, in the presence and absence of MTShOGG1. The change in mitochondrial membrane potential (Dc m ) was monitored by measuring the shift in the fluorescence of the emitted light of JC-1. Induced
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Vector -Dox Vector -Dox hOGG1 -Dox hOGG1 -Dox 2-ME + -+ -hOGG1 COX II Figure 1 Expression of hOGG1 targeted to mitochondria. HeLavector-only and mitochondrialy targeted hOGG1 (MTS-hOGG1) stably, transfected cells were grown in Dulbecco's modified Eagle's medium (DMEM) medium with 800 mg ml À1 G418 and 200 mg ml
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hygromycin. Cells were grown in the presence or absence of 1 mg ml À1 doxycycline for 72 h. A 20 mg of mitochondrial protein lysates was separated on standard sodium dodecyl sulphatepolyacrylamide gel electrophoresis (a). HeLa cells grown in the absence of doxycycline were treated with 500 nM 2-methoxyestradiol (2-ME) for 24 h. SDS-PAGE was performed using 20 mg of mitochondrial lysates (b). Western blot analysis was performed using anti-hOGG1 antiserum. Protein extracts in each lane are as indicated. Even loading was confirmed by re-probing the membrane with cytochrome c oxidase II (COX II) antibody.
hOGG1 protects 2-ME-induced mitochondrial damage A Chatterjee et al HeLa clones were treated with 500 nM 2-ME or vehicle for 24 h, before JC-1 staining was carried out. Our results indicated a hyperpolarization of the mitochondrial membrane in the vector-only-transfected cells after 2-ME treatment (Figure 3f , see histogram marked þ 2-ME), whereas in the MTS-hOGG1-expressing cells no shift in mitochondrial membrane potential was observed with 2-ME treatment (Figure 3a , compare À2-ME with þ 2-ME). An increase in mitochondrial membrane potential has been associated with Fas-induced apoptosis (Banki et al., 1999; Itoh et al., 2004) . Hence to determine the involvement of Fas activation in 2-MEinduced apoptosis in HeLa in the absence of hOGG1, the cells were treated with 10 mg ml À1 of Fas inhibitors cerulenin and C75 and co-treated with 500 nM 2-ME for 24 h. Co-treatment of vector-only-transfected cells with 2-ME and 10 mg ml À1 of either C75 or cerulenin reverted the hyperpolarization induced by 2-ME (compare Figures 3g and h with Figure 3f , see histogram marked þ 2-ME). In the MTS-hOGG1-expressing cells, no change in membrane potential was observed when cells were co-treated with 2-ME and 10 mg ml À1 of either C75 or cerulenin (compare Figures 3b and c with Figure 3a , see histogram marked þ 2-ME). Treatment of either vector-only or MTS-hOGG1 cells with C75 or cerulenin alone did not cause any significant change in membrane potential (Figures 3d, e, i and j) .
Inhibition of 2-ME induced apoptosis by hOGG1 Since mitochondrial membrane hyperpolarization was inhibited in the presence of Fas inhibitors, we sought to study the induction of apoptosis by 2-ME in the presence and absence of Fas inhibitors. Annexin V and PI staining indicated that in the vector-only-transfected cells, 2-ME induced 14.8% of cells into apoptosis (Figure 4b ), whereas the untreated cells showed a baseline apoptosis of only 5.26% (Figure 4a ). In the presence of MTS-hOGG1 treatment with 2-ME did not have a significant effect on the percentage of apoptotic cells (5.6 and 6.1%, respectively; Figures 4e and f). Cotreatment of the HeLa cells with the Fas inhibitor cerulenin resulted in an inhibition of 2-ME-induced apoptosis in the vector-only-transfected cells (8.3 and 9.3%; Figures 4c and d) . The percentage of apoptotic cells remained unaffected in the MTS-hOGG1-expressing cells in the presence of cerulenin with or without 2-ME (7.3 and 7.1%, respectively; Figures 4g and h). Similar results were obtained with C75 and 2-ME cotreatment (data not shown).
Caspase, PARP cleavage by 2-ME and hOGG1
Having observed that MTS-hOGG1 inhibits 2-MEinduced apoptosis, we examined the effect of 2-ME on caspase activation and protein poly(ADP-ribose) Vector-C75+2ME hOGG1-C75+2ME Vector-Cerulenin+2ME hOGG1-Cerulenin+2ME µM of 2ME 5µM 2-ME 20µM 2-ME Figure 2 Cell survival of hOGG1-regulated cells. HeLa cells transfected with indicated plasmids were grown in regular growth media, for 72 h with or without Dox as indicated. The cells were plated at a density such that they reached 70% confluence on the day of the treatment. The cells were then treated with 1, 5, 10, 20 and 40 mM 2-methoxyestradiol (2-ME) (a) for 24 h and with 5 mM (b) and 20 mM (c) 2-ME for the indicated time periods. (d) The HeLa cells were pre-treated with Fas inhibitors C-75 and cerulenin 10 mg ml À1 each for 2 h and then co-treated with indicated concentrations of 2-ME for 24 h. Cellular survival was assessed using the MTT cell proliferation assay kit. Error bars represent s.d. of three experiments. Statistical significance is indicated by the asterisk (*), where 0.05oP>0.001.
hOGG1 protects 2-ME-induced mitochondrial damage A Chatterjee et al polymerase (PARP) cleavage in the vector and MTShOGG1 stable clones. HeLa cells were grown in the absence of doxycycline for 3 days and exposed to 500 nM 2-ME or vehicle for 24 h. Caspase-3 and PARP cleavage were observed in the vector-transfected cells after 2-ME treatment, whereas minimal activation of both caspase-3 and PARP were observed in the MTS-hOGG1-expressing cells (Figure 5a , compare lane 2 with 4). Treatment Mitochondrial membrane potential after 24 h treatment with 2-methoxyestradiol (2-ME), without Dox. HeLa cells were stained with JC1 (a dye that oligomerizes in normal mitochondria and fluoresces red) reagent for 15 min; after washing, cell fluorescence was measured on a flow cytometer using Fl1 and Fl2 channels. Increase of red fluorescence indicates hyperpolarization of mitochondrial membrane potential (Dc m ). The mean red fluorescence of induced mitochondrialy targeted hOGG1 (MTS-hOGG1)-(a-e) and vector-only-transfected cells (f-j) was measured in the presence and absence of 10 mg ml
À1
Fas inhibitors cerulenin and C75, with or without 500 nM 2-ME for 24 h as indicated. A shift to the right in the presence of 2-ME indicates hyperpolarization of the membrane.
hOGG1 protects 2-ME-induced mitochondrial damage A Chatterjee et al of vector-only-transfected cells and MTS-hOGG1-expressing cells with the Fas inhibitor C75 and 2-ME resulted in a significant decrease in the PARP cleavage as shown by western blot (Figure 5a , compare lane 2 with 6, and lane 4 with 8). Furthermore, the presence of C75 led to the reduction in the cleavage of caspase-3, which was below the detectable limits for both vector and MTS-hOGG1 cells (Figure 5a , compare lane 2 with 6, and lane 4 with 8). Similar results were obtained with cerulenin and 2-ME co-treatment (data not shown). We also observed higher caspase-9 cleavage in the vector-transfected cells in the presence of 2-ME (50.1%), compared to the MTS-hOGG1 transfected cells (15.6%) (Figure 5b , compare lane 2 with 4). Western blot analysis of Bcl-2 protein showed that in the vectortransfected cells there was a significant decrease in the anti-apoptotic protein Bcl-2 in the presence of 2-ME compared to the MTS-hOGG1-expressing cells exposed to 2-ME. Higher Bid cleavage was observed in the presence of 2-ME in the vector-transfected cells compared to the MTS-hOGG1 cells treated with 2-ME, as evidenced by the tBid/b-actin ratio (Figure 5b , compare lane 2 with 4) (This antibody was unable to detect the parent Bid band and could only identify the 15 kDa tBid band, shown here.) We studied the expression of Fas in the HeLa clones in the presence and absence of 2-ME. Our results indicate that in the vector-transfected cells, there was higher expression of Fas when compared to the MTS-hOGG1-expressing cells in the presence and absence of 2-ME (Figure 5b , compare lane 1 with 3, and lane 2 with 4). Analysis of mitochondrial and cytosolic fractions of the vector-and hOGG1-transfected cells in the presence of 2-ME showed higher release of cytochrome c in the cytosol of the vector-transfected cells, compared to the hOGG1 cells exposed to 2-ME (Figure 5c ). Measurement of reactive oxygen species (ROS) levels did not show any significant difference between the 2-ME treated and untreated cells (data not shown). Furthermore, analysis of superoxide dismutase (SOD) also did not reveal any decrease in the scavenging enzyme in the presence of 2-ME (data not shown). Western blot analysis indicated that the HeLa cells expressed high amounts of SOD (Figure 5d ), but no difference was observed in the expression pattern of both Mn-SOD and Cu/Zn-SOD with 2-ME treatment.
hOGG1 prevents modification of cell cycle progression in response to 2-ME Cell cycle analysis by ModFit LT software showed a huge increase in the G 2 /M cell population in the vectortransfected cells after 2-ME treatment. In the untreated vector-transfected cells the G 2 /M population was 19.65% (Figure 6a) , while in the presence of 2-ME the G 2 /M population increased to 93.62% (Figure 6b ). When compared with the MTS-hOGG1-transfected cells, the untreated cells displayed a similar population at G 2 /M (18.42%; Figure 6c ), which increased to only 46.72% (Figure 6d ) upon exposure to 2-ME.
hOGG1 protects mitochondrial matrix injury upon exposure to 2-ME Our above-mentioned data indicates that hOGG1 protects the cells exposed to 2-ME. We, therefore, analysed the citrate synthase activity, the marker enzyme for the mitochondrial matrix (Srere, 1968; Trounce et al., 1996; Morgunov and Srere, 1998) , in the induced HeLa clones and treating them with 500 nM 2-ME for 24 h, to assess the presence of intact mitochondria. Our results indicated that in the vectoronly-transfected cells there was a fourfold decrease in the level of citrate synthase enzyme activity in response 
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In the presence of MTS-hOGG1, the level of citrate activity remained unaffected in the presence or absence of 2-ME, indicating that mitochondrial matrix damage by 2-ME was minimal with the overexpression of MTShOGG1 (Figure 7 ).
MTS-hOGG1 protects the cells from the cytotoxic effect of 2-ME Since we observed mitochondrial matrix damage in the presence of 2-ME, we further studied the cytotoxic effect of the drug on the cells by measuring lactate dehydrogenase (LDH) release in the culture medium, as an indicator of cell membrane damage. The presence of MTS-hOGG1 resulted in decreased LDH release even at the basal level, that is, without 2-ME treatment. Upon 24 h exposure of the induced HeLa clones to 500 nM 2-ME, the LDH release was 0.70 U ml À1 in the vectortransfected cells, whereas in the presence of MTShOGG1 the amount of LDH released was only 0.3 U ml À1 , indicating that MTS-hOGG1 protects the cells from the cytotoxic effects of 2-ME (Figure 8 ).
Discussion
We and others have shown that mtDNA repair and cellular survival are enhanced by targeting recombinant -Actin vector Vector +2ME hOGG1 hOGG1+2ME
Cu /Zn SOD
Mn SOD
Vector Mito Vector +2MECytoplasm
Vector +2MEMito Vector Cytoplasm hOGG1 Mito hOGG1 +2ME Cytoplasm hOGG1 +2ME Mito hOGG1 Cytoplasm
Cytochrome C COX II
0.25 0.09 0.52 0.15 Figure 5 Sequence of activation of caspases in 2-methoxyestradiol (2-ME)-challenged HeLa cells. HeLa cells were treated with 10 mg ml À1 of Fas inhibitor C75 followed by co-treatment with 2-ME in the absence of Dox. Subsequently, cell lysates were separated and probed with protein poly(ADP-ribose) polymerase (PARP) and caspase-3 (a). A 30 mg of cellular lysates was loaded as indicated in each lane. Total cellular extract was normalized for total protein content and analysed by immunoblotting using b-actin antibodies. (b) Western blot analysis of Bcl-2, caspase-9, t-Bid and Fas protein expression in relation to treatment with 2-ME. (c) Release of cytochrome c from mitochondria in cells exposed to 2-ME as demonstrated by western blot of mitochondrial and cytosol fraction prepared from vector-only-and mitochondrialy targeted hOGG1 (MTS-hOGG1)-transfected cells. Protein extract in each lane is as indicated with equivalent amounts of protein for each sample (30 mg). (d) Expression profile of Cu/Zn-SOD and Mn-SOD in HeLa cells after 2-ME treatment.
hOGG1 protects 2-ME-induced mitochondrial damage A Chatterjee et al hOGG1 to the mitochondria in HeLa cells (Dobson et al., 2000; Rachek et al., 2002; Chatterjee et al., 2006) . Furthermore, experiments targeting hOGG1 to mitochondria have been shown to protect cells from menadione-induced oxidative stress (Druzhyna et al., 2003) , apoptosis evoked by xanthine oxidase (Ruchko et al., 2005) , fatty-acid-induced apoptosis (Rachek et al., 2006b ) and nitric-oxide-induced mtDNA damage (Druzhyna et al., 2005; Rachek et al., 2006a) . These studies have confirmed that hOGG1, when expressed in mitochondria, enhances mtDNA repair and protects cells from damage-induced death. These findings led us to hypothesize that this recombinant enzyme could provide protection against mtDNA damage produced by an endogenous metabolite such as 17b-estradiol.
17b-Estradiol and its metabolites have been shown to inhibit DNA synthesis, collagen synthesis and cell proliferation (Dubey et al., 1998; Gui and Zheng, 2006) . Moreover, there has been an emphasis on the activation of stress-related pathways such as hypoxia inducible factor-a, tumor necrosis factor-a and Jun N-terminal kinase (JNK) in response to 2-ME (Mooberry, 2003; Djavaheri-Mergny et al., 2003b; Hagen et al., 2004) . Currently, little information is available on the functional involvement of the BER pathway in 2-MEinduced cell lethality. It has been demonstrated that p53 þ / þ cells treated with 2-ME showed a significant increase in the level of 8-oxoG (Achanta and Huang, 2004) . The BER pathway repairs 8-oxoG-induced damage, and mitochondrial DNA is an easy target for oxidative damage compared to nuclear DNA (Dianov et al., 2001) . hOGG1, an important member of the BER family, plays an essential role in repairing damaged DNA by removing 8-oxoG opposite cytosine (Vidal et al., 2001; Audebert et al., 2002; Parlanti et al., 2002; Ide and Kotera, 2004) . Low expression of hOGG1 is expected to sensitize cells to oxidative damage. Our analysis of cellular survival after exposure to 2-ME showed that the vector-only-transfected cells exposed to 5 mM 2-ME for 24 h had a marked decrease in the survival when compared to MTS-hOGG1-expressing cells. Upon the exposure of the cells to the same concentration of 2-ME for longer time periods of 48 and 72 h, there was further decrease in the cellular survival of vector-only-transfected cells to 20 and 10%, respectively, compared to the hOGG1-expressing cells, in which the cellular survival was maintained at 40% at both time periods. Our previous studies in lung cancer also demonstrated that the expression level of hOGG1 can determine cellular survival upon exposure to Vec Vec+2ME OGG1 OGG1+2ME
LDH Activity * Figure 8 Cytotoxicity (lactate dehydrogenase (LDH) release) in the presence of 2-methoxyestradiol (2-ME). A significant increase in the amount of LDH released in the medium after 24 h treatment with 2-ME was observed in the vector-only-transfected cells compared to the cells expressing mitochondrialy targeted hOGG1 (MTS-hOGG1). The data are presented as means ± s.d. All experiments were performed in triplicate. Statistical significance is as indicated. Po0.002.
hOGG1 protects 2-ME-induced mitochondrial damage A Chatterjee et al oxidative damaging agents like H 2 O 2 (Mambo et al., 2005) . Taken together, our current study highlights the importance of MTS-hOGG1 in cellular protection against DNA damaging agents such as 2-ME and the importance of this gene for the maintenance of cellular survival after stress. Mitochondria are a major source of superoxide production. 2-ME has been shown to increase superoxide production by inhibiting cellular SODs (Huang et al., 2000) . In our current study, we were unable to detect any change in SOD expression in the presence of 2-ME and no significant production of ROS was observed. Our observation is also in agreement with the previous studies by Kachadourian et al. (2001) . We attribute these results to the fact that there may be fundamental differences between cell types or between different cell lines of various cancer types. A possible reason for this variability may also be due to the fact that increased expression of MnSOD has been associated with p53 deficiency (Pani et al., 2000) . The same group and online information by American type cell culture indicates that p53 expression is low in HeLa cells.
We reasoned that 2-ME might cause mitochondrial damage by attacking mitochondrial membrane integrity. To test this hypothesis, we examined the integrity of mitochondrial membranes of 2-ME-treated cells by measuring mitochondrial transmembrane potential. Under our experimental conditions, 24 h incubation with 2-ME resulted in an increase in mitochondrial membrane potential, followed by higher activation of caspase-3 and -9, cleavage of Bid to tBid and PARP cleavage in the cells lacking MTS-hOGG1. Increased mitochondrial membrane potential with subsequent activation of caspase-9, Bid cleavage and cytochrome c release have been associated with Fas-mediated apoptosis (Banki et al., 1999; Itoh et al., 2004) . We attribute the increased mitochondrial potential in the vector-only-transfected cells to Fas-induced apoptosis. Involvement of the Fas/JNK pathway has been reported by other researchers in human leukemia and prostate cancer cells (LaVallee et al., 2003; Shimada et al., 2004; Gao et al., 2005) . Treatment of vector-only-transfected HeLa cells with Fas inhibitors cerulenin or C75 in combination with 2-ME resulted in the reversion of membrane hyperpolarization. This observation was further supported by our apoptosis experiments where 2-ME-induced apoptosis in the vector-only-transfected cells was strongly inhibited in the presence of Fas inhibitor cerulenin. We also noted that the presence of MTS-hOGG1 resulted in the inhibition of 2-ME-induced hyperpolarization and apoptosis even in the absence of Fas inhibitors. Our western blot data show that treatment of both MTS-hOGG1-expressing cells and vector-only-transfected cells with 2-ME in combination with Fas inhibitor C75 resulted in a significant decrease in the activation of caspase-3 and PARP cleavage. Furthermore, we also observed a decrease in the level of Fas expression in the MTS-hOGG1 expressing cells, suggesting that expression of this enzyme is able to block apoptosis induced through the Fas pathway.
2-ME has been demonstrated to cause G 2 /M arrest in several cancer types (Qanungo et al., 2002; Li et al., 2004a, b) , as we observe here. We believe this decrease in G 2 /M population of cells in the presence of hOGG1 is due to the protection this protein imparts to 2-MEinduced damage and not due to the regulation of hOGG1 itself, as it is well established that the hOGG1 gene is not regulated by cell cycle and is constitutively expressed (Dhenaut et al., 2000 (Dhenaut et al., , 2001 . Furthermore, cytotoxic effects of 2-ME studied by other groups showed an increase in LDH release (Nabi et al., 1986; Kachadourian et al., 2001) , in this study we found that the presence of recombinant hOGG1 protects the cells from the cytotoxic effects of 2-ME based on our LDH data. Thus, our results show that 2-ME-induced damage to mtDNA may contribute to a decrease in cellular survival, induction of cell cycle arrest, mitochondrial membrane hyperpolarization and apoptosis via the Fas activation. Although our current experiments show that hOGG1 protects the cells from 2-ME-induced damage, we do not rule out the possibility that the overexpression of OGG1 could be damage inducing after longer exposure to other DNA damaging agents. Earlier studies have demonstrated that the overexpression of other DNA glycosylase in human or bacterial cells have led to imbalance in the BER pathway (Blaisdell and Wallace, 2001; Fishel et al., 2003; Yang et al., 2004; Rinne et al., 2005) . This may be due to the fact that BER is a multiple gene repair process and may generate more DNA damage in cells because of imbalance in one of its proteins. To explain the protective effect of MTS-hOGG1 in 2-ME cells, we hypothesized that it is possible that OGG1 has other yet unknown effects on mitochondria in addition to DNA repair. Studies have shown increased damage of mtDNA by other anticancer agents (Segal-Bendirdjian et al., 1988; Modica-Napolitano et al., 1996) and the dependence on mitochondria for the cellular response to cancer chemotherapy (Singh et al., 1999) . Increased oxidative lesions are also found in mtDNA in individuals with a variety of chronic diseases (Corral-Debrinski et al., 1994; Hutchin and Cortopassi, 1995; Davis et al., 1997; Schapira, 1999; Wallace, 1999 Wallace, , 2000 . A beneficial gene therapeutic strategy for the prevention/delay of such diseases may be accomplished by regulating the expression of DNA repair genes in the mitochondrial genome. Additionally, the regulation of the activity of DNA repair genes may further increase cell death during cancer treatment or protect normal cells from undue toxicity.
Materials and methods
Cell culture
HeLa cells transfected with pTet-Off plasmid (Clontech, Mountain View, CA, USA) and pTRE2hyg/MTS-OGG1 plasmid were maintained in DMEM (Invitrogen, Carlsbad, CA, USA) supplemented with 10% fetal bovine serum (Clontech), 800 mg ml À1 G418 (Geneticin, Cellgro, VA, USA), 200 mg ml À1 hygromycin B and 1 mg ml À1 doxycycline with hOGG1 protects 2-ME-induced mitochondrial damage A Chatterjee et al
. Doxycycline was withdrawn from the medium of Dox-maintained clones 3 days before any experiment. Similarly, a pTRE2hyg vector without the insert transfected to the Tet-Off HeLa cells were used as a control. The above-mentioned stable clones were a kind gift from Dr Glenn Wilson (University of South Alabama, Mobile, AL, USA).
Cell viability assay
HeLa-MTS-hOGG1 and HeLa-vector were grown in 35 mm, six-well culture plates with and without doxycycline (dox) for 3 days. The cells were rinsed with Hanks' balanced salt solution (HBSS) and treated with 0, 1, 5, 10, 20 and 40 mM 2-ME for 24, 48 and 72 h in complete medium at 37 1C in 5% CO 2 incubator. For treatment beyond 24 h, media was changed in the cells with 2-ME at the mentioned concentrations at every 24 h. After the desired time of exposure, the drug containing medium was aspirated, the cells were rinsed with HBSS, and MTT assay was performed as described in (Chatterjee et al., 2006) . All experiments were performed in triplicate.
Western blot
Whole cell extracts of MTS-hOGG1-expressing cells and vector only transfected cells were prepared using RIPA buffer (10 mM Tris pH 7.4, 150 mM NaCl, 5 mM EDTA, 1% Triton-X-100, 0.1% SDS) containing protease inhibitors (Roche Diagnostics, Indianapolis, IN, USA cat no. 1697498) and 1 mM phenylmethylsulphonyl fluoride. Western blot analysis was performed as described by (Mambo et al., 2002) using 20 mg protein lysates for each protein antibody studied. Nitrocellulose membranes were hybridized with primary antibodies and developed with Amersham developer as per the manufacturer's instructions. Mitochondrial extracts of HeLa cells expressing MTS-hOGG1 and vector-only-transfected cells were prepared as described by (Chatterjee et al., 2006) . Caspase-9, PARP, Bcl-2, Bid, Bad and cytochrome c antibodies were obtained from Santa Cruz Biotechnology (Santa Cruz, CA, USA). hOGG1 antibodies were obtained from Novus Biologicals (Littleton, CO, USA). Cu/Zn-SOD and Mn-SOD antibodies were obtained from Calbiochem (San Diego, CA, USA). Loading control for the proteins was performed by re-probing the membrane with b-actin monoclonal antibodies (Sigma, St Louis, MO, USA). To confirm the presence of mitochondrial extract, the membrane was re-probed with cytochrome c oxidase II (COX II) antibody (Molecular Probes, Invitrogen). As it was confirmed that expression of hOgg1 in mitochondria was Dox-dependent, all further experiments were performed in the absence of Dox, unless indicated otherwise.
Measurement of mitochondrial membrane potential activity
We used a fluorescent dye JC-1 to measure changes in mitochondrial membrane potential (Reers et al., 1991) . Once loaded into the mitochondria, JC-1 undergoes aggregate formation in the high-potential regions. This method has been validated for a reliable analysis of Dc m changes in mitochondria (Salvioli et al., 1997) . The green fluorescent JC-1 (5,5 0 ,6,6 0 -tetrachloro-1,1 0 ,3,3 0 -tetraethylbenzimidazoylcarbocyanine iodine, T-3168) exists as a monomer at low membrane potential. Mitochondrial function was monitored following the treatment of the induced HeLa cells with 500 nM 2-ME for 24 h. Briefly, after experiment treatment cells were incubated for 15 min at 37 1C in a 5% CO 2 incubator in the presence of 10 mM JC-1 and cells were analysed using FACStar flow cytometer (Becton Dickinson, Franklin Lakes, NJ, USA) as per the manufacturer's instructions (Stratagene, La Jolla, CA, USA).
Annexin V/PI staining Apoptosis was determined by staining cells with annexin V-fluorescein isothiocyanate and PI labeling as per the manufacturer's instructions (Becton Dickinson). Annexin V was used to detect early apoptotic cells during the apoptotic progression. Briefly, HeLa clones were induced for 3 days and were treated with or without 10 mg ml À1 of Fas inhibitors (cerulenin and C75) and 500 nM 2-ME for 24 h. The prepared cells were washed twice with cold phosphate-buffered saline (PBS), re-suspended in 100 ml of binding buffer at a concentration of 1 Â 10 6 cells ml À1 and stained with Annexin V and PI. The cells were analysed on the FACStar flow cytometer (Becton Dickinson). Data analysis was performed using the software 'Cell Quest'.
Cell cycle analysis by flow cytometry Cell cycle analysis was performed as described previously (Planas-Silva and Weinberg, 1997) . Briefly, cells were cultured in the absence of doxycycline and then treated with 500 nM 2-ME for 24 h. Control experiments were run with vehicle treatment only for 24 h. The cells were harvested by trypsinization, pelleted and resuspended in 1 ml of PBS. RNase A was added (final concentration, 2 mg ml À1 ). Cells were further stained with 50 mg ml À1 propidium iodide solution. Cell cycle analysis was carried out with a Becton Dickinson FACScan flow cytometer. Data were analysed with the ModFit LT software (Verity Software House Inc., Topsham, ME, USA).
Cytotoxicity assays
Membrane damage was evaluated by measuring the LDH release in the culture medium (Fanizza et al., 2007) . The HeLa cells were cultured in the absence of doxycycline for 3 days and treated with 500 nM 2-ME or the vehicle for 24 h, before the media was collected for the LDH release assay. A control blank was run at all times without any cells. LDH is an oxidoreductase that catalyses the inter-conversion of lactate and pyruvate. The assay is based on the reduction of NAD by the action of LDH. The resulting reduced NAD (NADH) is utilized in the stoichiometric conversion of a tetrazolium dye. The resulting colored compound was measured spectrophotometrically (A490-A690 nm) using a Molecular Devices Spectra Max 250, 96-well plate reader (Sunnyvale, CA, USA). The LDH-cytotoxicity detection kit (Roche Diagnostics) was used for all experiments. Each experiment was performed in triplicate.
Citrate synthase activity Citrate synthase activity was determined using a commercially available kit from Sigma. HeLa stable clones were cultured in the absence of doxycycline and treated with 500 nM 2-ME or the vehicle for 24 h. Results were obtained spectrophotometrically at room temperature (412 nm). Each experiment was performed in triplicate. Citrate synthase activity was calculated as per the manufacturer's instructions.
